Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļFTRE
āļāļ·āđāļāļāļĢāļīāļĐāļąāļFortrea Holdings Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 16, 2023
āļāļĩāļāļĩāđāļThakrala (Anshul)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ15500
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 16
āļāļĩāđāļāļĒāļđāđ8 Moore Drive
āđāļĄāļ·āļāļDURHAM
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ27709
āđāļāļĢāļĻāļąāļāļāđ18774950816
āđāļ§āđāļāđāļāļāđhttps://www.fortrea.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļFTRE
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 16, 2023
āļāļĩāļāļĩāđāļThakrala (Anshul)
Mr. Peter M. Neupert
Chairman of the Board
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
Mr. Edward A. Pesicka
Independent Director
Mr. David Ross Smith
Independent Director
Ms. Machelle Sanders
Independent Director
Ms. Jill Mcconnell
Chief Financial Officer
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
Ms. Hima B. Inguva
Investor Relations
Ms. Erin L. Russell
Independent Director
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Peter M. Neupert
Chairman of the Board
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
Mr. Edward A. Pesicka
Independent Director
Mr. David Ross Smith
Independent Director
Ms. Machelle Sanders
Independent Director
Ms. Jill Mcconnell
Chief Financial Officer
Brandes US Small-Mid Cap Value ETF
Invesco S&P SmallCap Health Care ETF
Invesco S&P SmallCap 600 Revenue ETF
Invesco S&P SmallCap 600 Pure Value ETF
Schwab Fundamental U.S. Small Company ETF
iShares S&P Small-Cap 600 Value ETF
ProShares Ultra Nasdaq Biotechnology
State Street SPDR S&P 600 Small Cap Value ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Brandes US Small-Mid Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ1.39%
Invesco S&P Spin-Off ETF
āļŠāļąāļāļŠāđāļ§āļ0.97%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ0.58%
Invesco S&P SmallCap 600 Revenue ETF
āļŠāļąāļāļŠāđāļ§āļ0.25%
Invesco S&P SmallCap 600 Pure Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.23%
Schwab Fundamental U.S. Small Company ETF
āļŠāļąāļāļŠāđāļ§āļ0.17%
iShares S&P Small-Cap 600 Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.16%
Humankind US Stock ETF
āļŠāļąāļāļŠāđāļ§āļ0.14%
ProShares Ultra Nasdaq Biotechnology
āļŠāļąāļāļŠāđāļ§āļ0.14%
State Street SPDR S&P 600 Small Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.13%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ